EP04: Using Gene Sequencing Technology to Enhance Anti-doping Efforts in Sports
Doping scandals have long plagued the Olympic Games' history, casting a shadow over the integrity of international sports and highlighting the ongoing need for more robust anti-doping strategies. These incidents have led to global calls for stricter enforcement and innovative approaches to safeguard the spirit of fair competition.
Among those at the forefront of this effort is Professor Yannis Pitsiladis from Hong Kong Baptist University, a distinguished leader in anti-doping research and a key member of the International Olympic Committee’s Medical and Scientific Commission.
Professor Pitsiladis is recognized worldwide for pioneering work integrating advanced scientific techniques, particularly gene sequencing and genomics, into anti-doping initiatives. His groundbreaking research is focused on staying ahead of those who attempt to gain an unfair advantage through banned substances, offering a new frontier in the fight against doping. By applying cutting-edge genetic technologies, he is helping to redefine the landscape of sports integrity and ensuring that athletes compete on a level playing field.
Tune in below to join the conversation!
MGI Podcast EP04: Using Gene Sequencing Technology to Enhance Anti-doping Efforts in Sports
After spending 15 years at the University of Glasgow in Scotland, where he developed the world’s largest known DNA biobank of elite athletes and one of the largest DNA biobanks of school-aged children, Yannis Pitsiladis was appointed Professor of Sport and Exercise Science at the University of Brighton in late 2013.
During his decade-long tenure at Brighton, he successfully established the International Federation of Sports Medicine Collaborating Centre of Sports Medicine (FIMS CCSM) and, as its founding Director, developed it into a unique center of excellence.
Recently, Yannis has taken on a new role as Professor and Head of the Department of Sport, Physical Education, and Health (SPEH) at Hong Kong Baptist University, where he plans to create a cutting-edge center of excellence in sport and exercise science and medicine.
Watch EP03 "NGS in Transplant Immunology and Resolution of Genotyping" Now
About MGI
MGI Tech Co., Ltd. (or its subsidiaries, together referred to MGI), is committed to building core tools and technologies that drive innovation in life science. Their focus lies in research & development, manufacturing, and sales of instruments, reagents, and related products in the field of life science and biotechnology. They provide real-time, multi-omics, and full spectrum of digital equipment and systems for precision medicine, agriculture, healthcare and various other industries.
Founded in 2016, MGI has grown into a leader in life science, serving customers across six continents and have established research, manufacturing, training, and after-sales service facilities globally. MGI stands out as one of the few companies capable of independently developing and mass-producing clinical-grade gene sequencers with varying throughput capacities, ranging from Gb to Tb levels. With unparalleled expertise, cutting-edge products, and a commitment to global impact, MGI continues to shape the trajectory of life sciences into the future. To learn more, please visit https://en.mgi-tech.com/ , Linkedin, X, and Youtube.
